Announced Thu, 30 Apr · 17:39 IST

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....

GKSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹122.62
prior close
₹124.73
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.7+3.6+3.7+4.4+0.5+0.8+6.7+14.1+16.2+14.8+14.7+6.8+4.4
Up moveDown movePending
AI summary

Gujarat Kidney and Super Speciality Ltd has submitted an initial disclosure under SEBI regulations for entities identified as Large Corporates. The filing reveals the company has outstanding borrowings of Rs 1.23 crore as of March 31, 2026. No credit rating has been assigned. Critically, the company has confirmed that it does not meet the criteria to be classified as a Large Corporate under SEBI guidelines. The disclosure was signed by the Company Secretary and CFO, with the filing referencing SEBI circulars dated October 2023 and August 2021.

Likely market impact

This is a routine compliance filing with no direct impact on shareholders. The company's confirmation that it is not a Large Corporate means it avoids additional disclosure obligations under SEBI's enhanced framework for large borrowers.